Publicaciones en colaboración con investigadores/as de Hospital Duran i Reynals (19)

2022

  1. Meat Intake, Cooking Methods, Doneness Preferences and Risk of Gastric Adenocarcinoma in the MCC-Spain Study

    Nutrients, Vol. 14, Núm. 22

2021

  1. Occupational heat exposure and breast cancer risk in the MCC-Spain study

    Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 2, pp. 364-372

  2. Risk of gastric cancer in the environs of industrial facilities in the MCC-Spain study

    Environmental Pollution, Vol. 278

2020

  1. Residential proximity to industrial pollution sources and colorectal cancer risk: A multicase-control study (MCC-Spain)

    Environment International, Vol. 144

  2. Validation of self-reported perception of proximity to industrial facilities: MCC-Spain study

    Environment International, Vol. 135

2018

  1. Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia

    Leukemia and Lymphoma, Vol. 59, Núm. 1, pp. 146-154

  2. Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy

    Leukemia, Vol. 32, Núm. 1, pp. 21-29

  3. The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 230-242

2017

  1. Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid

    Annals of hematology, Vol. 96, Núm. 7, pp. 1069-1075

  2. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols

    Leukemia and Lymphoma, Vol. 58, Núm. 1, pp. 145-152

  3. Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance

    American Journal of Hematology

  4. Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma

    Oncotarget, Vol. 8, Núm. 18, pp. 30410-30421

2014

  1. Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program

    Expert Opinion on Drug Safety, Vol. 13, Núm. 9, pp. 1165-1173

  2. Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients

    Leukemia Research, Vol. 38, Núm. 10, pp. 1199-1206

  3. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: Final results of the PETHEMA ALL-AR-03 trial

    Journal of Clinical Oncology, Vol. 32, Núm. 15, pp. 1595-1604

2011

  1. Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response

    Current Medical Research and Opinion, Vol. 27, Núm. 5, pp. 951-960

  2. Genotype of an individual single nucleotide polymorphism regulates DNA methylation at the TRPC3 alternative promoter

    Epigenetics, Vol. 6, Núm. 10, pp. 1236-1241

2010

  1. Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial

    Haematologica, Vol. 95, Núm. 1, pp. 87-95

2006

  1. Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy

    International Journal of Cardiology, Vol. 112, Núm. 2, pp. 202-206